Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
Public ClinicalTrials.gov record NCT06354660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and inadequate glycemic control. The study will last about 11 months and may include up to 11 visits.
Study identification
- NCT ID
- NCT06354660
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 537 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 9, 2024
- Primary completion
- Jan 21, 2026
- Completion
- Feb 19, 2026
- Last update posted
- Mar 4, 2026
2024 – 2026
United States locations
- U.S. sites
- 29
- U.S. states
- 17
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Scottsdale Clinical Trials | Scottsdale | Arizona | 85260 | — |
| Tucson Clinical Research Institute | Tucson | Arizona | 85712 | — |
| San Fernando Valley Health Institute | Canoga Park | California | 91304 | — |
| Ark Clinical Research | Long Beach | California | 90815 | — |
| Northeast Research Institute (NERI) | Fleming Island | Florida | 32003 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| Ezy Medical Research | Miami | Florida | 33175 | — |
| Clinical Research of Central Florida | Winter Haven | Florida | 33880 | — |
| Trinity Research Centers | Marietta | Georgia | 30064 | — |
| Cotton O'Neil Clinical Research Center | Topeka | Kansas | 66606 | — |
| NECCR PrimaCare Research | Fall River | Massachusetts | 02721 | — |
| Clinical Research Professionals | Chesterfield | Missouri | 63005 | — |
| Boeson Research MSO | Missoula | Montana | 59804 | — |
| NJ MedCare & NJ Heart | Linden | New Jersey | 07036 | — |
| Accellacare - Wilmington - 1917 Tradd Court | Wilmington | North Carolina | 28401 | — |
| Providence Health Partners-Center for Clinical Research | Dayton | Ohio | 45439 | — |
| Clinical Research of Philadelphia | Philadelphia | Pennsylvania | 19114 | — |
| Preferred Primary Care Physicians | Uniontown | Pennsylvania | 15401 | — |
| Delricht Research - Tobias Gadson Boulevard - Charleston | Charleston | South Carolina | 29407 | — |
| Lifedoc Research - Lenox Park Drive | Memphis | Tennessee | 38115 | — |
| Clinical Research Associates Inc | Nashville | Tennessee | 37203 | — |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | — |
| Prime Revival Research Institute, LLC | Flower Mound | Texas | 75028 | — |
| Valley Institute of Research - Fort Worth | Fort Worth | Texas | 76164 | — |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | — |
| Texas Valley Clinical Research | Weslaco | Texas | 78596 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
| MultiCare Rockwood Cheney Clinic | Cheney | Washington | 99004 | — |
| Eastside Research Associates | Redmond | Washington | 98052 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06354660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2026 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06354660 live on ClinicalTrials.gov.